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ABSTRACT  
Aims: The role of physical activity in the BMI-survival relationship in coronary heart disease 
is unclear. Our aim was to examine isolated and combined associations between BMI and 
physical activity, and mortality in subjects with coronary heart disease.. 
Methods and Results: 6 493 participants (34.4% women) with coronary heart disease from 
the Nord-Trøndelag Health Study, with examinations in 1986, 1996, and 2007, were followed 
until the end of 2014. We calculated hazard ratios (HR) for all-cause and cardiovascular 
disease mortality, estimated using Cox proportionate hazard regression adjusted for age, 
smoking, diabetes, hypertension, self-reported health status, and alcohol. 3 818 died (62.1 % 
of cardiovascular disease) during 30 (median 12.5) years of follow-up. Compared to BMI (in 
kg/m2) 18.5-22.4, BMI categories 25.0- 27.4, 27.5-29.9, and 30.0-34.9 had reduced all-cause 
mortality risk (HR, 0.80 [95% CI 0.72-0.90]; 0.80 [95% CI, 0.71-0.90]; 0.83 [0.74-0.95]), 
respectively. BMI categories 25.0-27.4 and 27.5-29.9 had reduced cardiovascular disease 
mortality risk (HR, 0.81 [95% CI, 0.70-0.94]; 0.83 [95% CI, 0.71-0.96]), respectively. 
Compared to physically inactive, all levels of physical activity were associated with reduced 
all-cause and cardiovascular disease mortality risk. In inactive, all BMI categories above 25.0 
had reduced all-cause mortality risk (HRs across BMI categories: 0.77, 0.79, 0.79, 0.74), 
whereas in subjects who were following or exceeding the recommended level of physical 
activity, BMI did not associate with survival.  
Conclusions: Overweight and obese subjects with coronary heart disease had reduced all-
cause and cardiovascular disease mortality, but such an obesity paradox was only seen in 
participants who did not adhere to current recommendations of physical activity.  
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HIGHLIGHTS 
• We found lower mortality risk in subjects with coronary heart disease who were 
overweight and obese.  
• In physically active subjects, however, BMI did not have a significant role for 
predicting survival.  
• These results suggest that physical activity is important to improve prognosis in 
subjects with coronary heart disease, and that body weight is of minor importance in 
secondary prevention as long as the subjects are physically active 
 
INTRODUCTION 
Obesity, most often defined as a body mass index (BMI; weight in kg/height in m2) ≥ 30, has 
been found to associate with cardiovascular disease risk 1, 2 and all-cause mortality 3, 4.  
However, there are observations indicating lower mortality among overweight and moderately 
obese subjects, both in the general population 5, and especially so in various patient groups 6-8. 
In subjects with stable coronary heart disease, meta-analyses have reported a favorable 
prognosis in overweight and mildly obese subjects 8, 9, compared to their leaner counterparts, 
which is often referred to as an “obesity paradox”. The benefits of increased adiposity is, 
however, attenuated in long-term versus short-term follow-up, indicating potential bias due to 
reversed causality 8.  
Previous studies have shown that  among coronary heart disease patients with a high 
cardiorespiratory fitness level, there is no obesity paradox, with the prognosis benefits of 
higher BMI confined to the groups with low cardiorespiratory fitness 10, 11. Aerobic fitness is a 
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robust predictor of survival in coronary heart disease 12, and although cardiorespiratory fitness 
has a strong genetic component, physical activity is the most important determinant of fitness 
in most adults. As both physical activity and BMI are important modifiable health indicators, 
their isolated and combined associations with mortality are clinically relevant 13, 14. 
To our knowledge, no previous study has explored the combined effect of BMI and 
physical activity for mortality in subjects with coronary heart disease. Furthermore, there 
exists few studies on the association between BMI and long-term survival in this population 
of patients, and it is suggested that the survival benefit of obesity disappear after 5 years of 
follow-up 8. 
To address the shortcoming in the existing literature, our aim was to assess the isolated 
and combined associations of physical activity and BMI with mortality risk in subjects with 
coronary heart disease over a long time of follow-up, and to determine if physical activity 
alters the relationship between adiposity and long-term survival in these patients.  
 
METHODS 
Study design and participants 
The Nord-Trøndelag Health Study (HUNT) started in 1984-1986 (HUNT-1), with subsequent 
waves in 1995-1997 (HUNT-2) and in 2006-2008 (HUNT-3) 15. In the HUNT studies, the 
entire adult population aged 20 years or older in Nord-Trøndelag county in Norway was 
invited. The participants attended a clinical examination and filled out detailed questionnaires 
about several lifestyle factors and health outcomes. Our analysis included men and women 
reporting to have coronary heart disease, as either angina pectoris and/or myocardial 
infarction, who had valid data on physical activity, BMI, diabetes, hypertension, self-reported 
health status, smoking and alcohol consumption in at least one HUNT wave (Figure 1). 
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Participants were excluded if they had a BMI of less than 18.5 due to limited statistical power 
in this group. The Regional Committee for Medical and Health Research Ethics in Central 
Norway (2014/1493) approved the study protocol.  
 
Assessment of BMI 
Height and weight were measured by trained nurses with participants wearing light indoor 
clothes and no shoes. BMI was calculated as weight in kilograms divided by the square of 
height in meters, and classified in following categories: 18.5 to 22.4 (reference), 22.5 to 24.9, 
25.0 to 27.4, 27.5 to 29.9, 30.0 to 34.9, and 35.0 or higher 16.  
 
Assessment of physical activity 
Participants were asked about their frequency, duration and intensity of leisure time physical 
activity at each HUNT wave. We grouped the subjects into four levels of physical activity, 
based on a previously published index 17. This index was made to categorize physical activity 
related to the current recommendations on physical activity to promote health in adults 18. 
Subjects who reported no physical activity were categorized as ‘inactive’. Subjects reporting 
physical activity at a level below the recommendations were categorized as ‘low’, subjects 
reporting to fulfill the recommendations were categorized as ‘recommended’, whereas those 
who reported to exceed the recommended level were classified as ‘high’.   
 
Ascertainment of Outcomes 
The primary outcome was death from any cause until the end of follow-up on December 31, 
2014. In addition, we assessed deaths from cardiovascular disease (International 
Classification of Diseases, Ninth Revision: 390-459; International Statistical Classification of 
Diseases, Tenth Revision: I00-99). It is mandatory for Norwegian physicians and public 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
  
6 
 
health officers to report deaths to the National Cause of Death Registry in Norway. Therefore, 
our study had a virtually complete follow-up.     
 
Assessment of Covariables 
The participants answered detailed questions about their cigarette smoking habits, alcohol 
consumption, health status, and prevalence of diabetes mellitus. Smoking was categorized as 
current, former, or never. Alcohol consumption was categorized as abstrainer, 0 drinks, 1-4 
drinks, or or ≥5 drinks, over a 14 days period. Self-reported health status was categorized as 
bad, not so good, good, or very good. Blood pressure was measured at on the right arm with 
cuffs adjusted according to the arm circumference, and after the participants had been sitting 
relaxed for five minutes. In HUNT-1, the measurements were done manually by trained 
nurses, and repreated twice. In HUNT-2 and HUNT-3, the measurements were done using 
automated divices, and repeated three times. We defined hypertension as systolic blood 
pressure ≥140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg and/or taking blood 
pressure medications. 
 
Statistical Analysis 
We compared the baseline characteristics of participants according to BMI categories using 
linear regression for continuous variables, and chi-square tests for categorical variables. 
Stratified Cox proportional hazard regression models, conditioning on sex were used to 
estimate hazard ratios with 95% confidence interval (CI) according to BMI categories, where 
BMI, physical activity and other confounders were updated over time. We adjusted for 
attained age as time scale and examination year in the crude analysis. In the multivariate 
models, we additionally adjusted for physical activity, smoking status, alcohol consumption, 
hypertension, self-reported health status, and prevalence of diabetes mellitus (yes/no). We 
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used a restricted cubic spline approach with five knots to explore whether all-cause mortality 
risk increased with BMI as a continuous exposure variable, using BMI of 20.5 as the 
reference.  
 We assessed effect modification by physical activity by adding the multiplicative 
interaction term between physical activity and BMI to the main model. To assess the 
association between BMI and mortality in different physical activity levels, we performed 
separate analyses for inactive, low, and recommended/high physical activity levels. In this 
analysis, the recommended and high physical activity categories were combined to avoid 
subgroups with too few events.  
We repeated our analyses without the first three years of follow-up to minimize the 
chance of bias due to reversed causality. We also repeated the analyses stratified according to 
smoking status, as statistical confounding by smoking is likely to be greater when we assess 
subjects who are selected based on coronary heart disease 19. The analyses were undertaken 
using Stata version 13.1 (StataCorp). All statistical tests were 2-sided, with a P value of less 
than 0.05 considered significant.  
 
RESULTS 
Table 1 shows selected baseline characteristics according to BMI categories in HUNT-1.  
There was a higher percentage of women in the two highest BMI categories (30.0-34.9 and ≥ 
35.0). Higher BMI categories were associated with hypertension and inversely associated with 
physical activity level and with current smoking. 
 
All-Cause Mortality 
Over 30 (median 12.5, IQR 14.1) years of follow up, 3 818 participants died. Compared to the 
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reference group of BMI 18.5-22.4, those with BMI 25.0-27.4, 27.5-29.9, and 30.0-34.9 had 
significantly reduced all cause mortality in the adjusted analysis. For those with BMI of 35 or 
above, the risk was not significantly different from the reference group (Table 2). The results 
did not change substantially when excluding the first three years of follow-up (a total of 696 
deaths, eTable 1). Estimates of adjusted HR for all-cause mortality according to BMI as a 
continuous exposure variable are presented in Figure 2.  
Compared to the inactive reference group, all active groups had reduced all cause 
mortality (Table 2). The recommended level of physical activity was associated with larger 
reduction in mortality risk compared to the low level, whereas exceeding the 
recommendations did not provide a further reduction. We did not see any change to this 
pattern when we excluded the deaths occurring during the first three years of follow-up 
(eTable 1).  
We observed a weak evidence (P for interaction = 0.04) for effect modification by 
physical activity for the association of BMI and all-cause mortality risk, and found divergent 
associations between BMI and mortality for those who were inactive versus those who were 
active (Figure 3). In inactive subjects, we saw reduced mortality in overweight (BMI 25.0-
27.4; hazard ratio, 0.77, 95% CI, 0.66-0.90; BMI 27.5-29.9; hazard ratio, 0.79, 95% CI 0.68-
0.92) and in obese participants (BMI 30.0-34.5; hazard ratio, 0.79, 95% CI 0.67-0.93;  BMI ≥ 
35.0; hazard ratio, 0.74, 95% CI, 0.59-0.93) (Figure 3, Panel C). In participants reporting low 
physical activity, we observed reduced mortality in those with BMI 22.5-25.0 (HR, 0.79, 95% 
CI, 0.64-0.97), BMI 25.0-27.4 (HR, 0.78, 95% CI, 0.64-0.96), and BMI 27.5-29.9 (HR, 0.80, 
95% CI, 0.65-0.99) (Figure 3, Panel E).  In participants adhering to or exceeding the 
recommended level of physical activity, none of the BMI categories had HRs significantly 
different from the reference category (Figure 3, Panel G). These associations were essentially 
unchanged when excluding deaths occurring in the first three years (Figure 3, Panels B, D, F, 
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and H).  
In subjects who had ever smoked, all BMI categories above the reference category had 
signinficantly reduced all-cause mortality, while in subjects who had never smoked only those 
with BMI 27.5-29.9 and 30.0-34.9 had reduced risk (eTable 2). Subjects who had ever 
smoked had larger all-cause mortality risk reduction associated with physical activity, 
compared to subjects who had never smoked (eTable 2). 
 
Cardiovascular Disease Mortality 
Of the total number of deaths, 62.1% (2 372 deaths) were due to cardiovascular disease. We 
saw a significantly reduced cardiovascular disease mortality in those with BMI 25.0-27.4 and 
BMI 27.5-29.9 (Table 2). When excluding the first three years of follow-up (a total of 509 
deaths), there was only a trend towards lower cardiovascular disease mortality in those with 
BMI 25.0-27.4 and BMI 27.5-29.9 (eTable 1).  
All active groups had significantly reduced cardiovascular disease mortality risk, 
compared to the inactive reference group (Table 2). Again, there was a larger risk reduction 
associated with recommended or higher physical activity level than with low physical activity.  
We observed no evidence for an effect modification of physical activity on the 
association between BMI and cardiovascular disease mortality (P for interaction = 0.13). 
When assessing BMI and cardiovascular disease mortality in separate groups according to 
physical activity level (eFigure 1), the findings are tempered by relatively small numbers in 
the various categories. However, in the inactive group, lower cardiovascular disease mortality 
was noted in those with BMI 25-27.4 and BMI 27.5-29.9, with strong trends in the higher 
BMI groups towards lower cardiovascular disease mortality, which were attenuated slightly if 
deaths during the first 3 years of follow-up were excluded. In the low physical activity group, 
we observed lower cardiovascular disease mortality in those with BMI 25-27.4, and a strong 
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trend of higher cardiovascular disease mortality in those with BMIs of 35 and higher. In the 
high physical activity group, BMI was not significantly associated with cardiovascular disease 
mortality.  
  
DISCUSSION 
Main results 
In our study on all-cause and cardiovascular disease mortality associated with different levels 
of BMI in a large cohort of subjects with coronary heart disease, we found improved survival 
in overweight and mildly obese subjects. Subjects who reported to be physically active had 
lower mortality risk, with larger reductions in those who were following or exceeding the 
current recommendations for physical activity. We observed a divergent association between 
BMI and survival in inactive versus active subjects, and our data indicate that in inactive 
subjects, all levels of overweight and obesity are associated with reduced moratlity risk. In 
contrast, among subjects with low physical activity, only those in the upper range of normal 
weight or overweight had reduced all-cause mortality risk, whereas in those with a high 
physical activity level, mortality was essentially equal across BMI categories.  
 
Comparison with previous studies and potential mechanisms 
Our data are in line with numerous pervious studies reporting a survival advantage associated 
with overweight and obesity in subjects with coronary heart disease 8, 9, 20-26, however, the 
current study shows the important and significant interaction between BMI, physical activity, 
and prognosis. The exact mechanisms for this obesity paradox is poorly understood, but 
several potential mechanisms have been suggested. Subjects with excess fat stores could have 
a higher metabolic reserve 27, and thus better tolerate disease-related weight loss in the acute 
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phase, compared to leaner subjects. However, in our study of long-term survival in stable 
coronary heart disease, we regard such protection as less relevant. Indeed, previous studies 
have indicated that short-term mortality is improved in overweight/obese subjects with 
coronary heart disease, whereas long-term mortality is not 24.  Genetic components are also 
suggested to play a role in the association between BMI and survival in subjects with 
coronary heart disease.23, 28. Subjects within all categories of BMI could have a genetic 
predisposition for coronary heart disease, however, potentially more subjects with low BMI 
have such predisposisiton, whereas a larger proportion of overweight/obese subjects gets 
coronary heart disease due to modifiable lifestyle factors. Another possible explaination for 
better prognosis in overweight/obese subjects, is that they receive more aggressive treatment 
than their leaner counterparts 29. 
Mons and collegueas 30 observed a reverse J-shaped association between physical 
activity and prognosis in subjects with stable coronary heart disease, with increased risk for 
adverse outcomes in inactive subjects as well as trends towards increased mortality also in 
subjects doing daily strenuous physical activity. Another recent study suggested that coronary 
heart disease patients with very high physical activity (eg approximately 30 miles per week of 
jogging or 46 miles per week of walking), there appeared to be loss in the protective effects of 
physical activity noted at lower levels 31, 32. Although our study did not differentiate between 
levels of physical activity exceeding the recommended level, we did not observe any 
indications of increased mortality risk associated with high levels of physical activity. 
Previous studies have found that cardiorespiratory fitness alters the relationship 
between adiposity and prognosis in subjects with coronary heart disease 10, 11 as an obesity 
paradox was only evident in the lower fit subjects. Our findings of no difference in survival 
between the different BMI categories in subjects who met or exceeded the recommended level 
of physical activity are in line with this, recognizing that generally cardiorespiratory fitness 
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correlates better with prognosis than does physical activity 33.  Although fitness is partly 
genetically determined, physical activity is a very important determinant 34, and our data 
support the independent effect of physical activity on prognosis in coronary heart disease. 
 
Study strengths and limitations 
Strenghts of our study include the large number of subjects with coronary heart disease and 
number of deaths, as well as the long follow-up period and the complete registration of 
deaths. The classification of BMI in multiple categories is also regarded as a strength of the 
study. We included subjects from a large, population based study with high participation rate, 
which likely improve the generalization of our findings. Furthermore, weight and height were 
objectively measured in the HUNT study.  
Some limitations to our study are worth notice. The questions about physical activity 
in HUNT2 were different than in HUNT1 and HUNT3. However, previous studies have found 
that the data on physical activity from both HUNT1 and HUNT2 shows associations with 
morbidity and mortality as expected 35-39. We did not have information about diet in our 
population, limiting our ability to determine if dietary patterns could explain some of the 
associations seen. BMI was used as the only measure of body composition, which  is not ideal 
as subjects with equal BMI could have different percentage of fat and  muscle mass. Waist 
circumference was measured in HUNT2 and HUNT3. However, as the reliability of weight 
and height measurements (and thus BMI) is higher that the reliability of waist circumference 
40
, we decided to only use BMI in the analyses. Of notice, the obesity paradox was not noted 
with waist circumference in some reports 41, 42, although this was noted in a very large study 
that also assessed cardiorespiratory fitness 10. Furthermore, it has been found that the same 
obesity paradox is evident when comparing patients with high and low percent body fat, as 
when comparing high and low BMI 10, 22, 43.  
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Reversed causality will always be a potential problem in studies assessing the relation 
between BMI and mortality in patients with coronary heart disease, as a low BMI might be 
due to progression of coronary heart disease or other underlying diseases. We tried to limit 
this by carefully adjusting for potential confounders, such as self-reported health status, 
smoking habits, hypertension, and diabetes. We also did secondary analyses excluding the 
first three years of follow up, and saw minimal effect on the associations.  
 
CONCLUSION 
Our study demonstrated that subjects with coronary heart disease who are overweight or 
mildly obese have better survival than their lean counterparts, and that all levels of physical 
activity is associated with improved survival. Our results also indicate that among coronary 
heart disease subjects who are physically active, BMI does not seem to associate strongly with 
survival.  
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Figure legends 
 
Figure 1. Flow chart of participants in the study. BMI = Body mass index. HUNT = The 
Nord-Trøndelag Health Study.  
 
Figure 2. Hazard ratios and 95% confidence intervals for all-cause mortality according to 
body mass index, adjusted for age, examination year, physical activity, smoking, diabetes, 
alcohol, hypertension, and health status. 
  
Figure 3. Hazard ratios for all-cause mortality according to body mass index.  
Panel A: All participants. Panel B: All participants, excluding the first 3 years of follow-up. 
Panel C: Participants who reported to be inactive. Panel D: Participants reported to be 
inactive, excluding the first 3 years of follow-up. Panel E: Participants reported to have low 
physical activity. Panel F: Participants reported to have low physical activity, excluding the 
first 3 years of follow-up. Panel G: Participants reported to have recommended or high 
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physical activity. Panel H: Participants reported to have recommended or high physical 
activity, excluding the first 3 years of follow-up.  
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Table 1. Baseline characteristics of the participants according to body mass index. 
 Body mass index*  
 Total 18.5-22.4 22.5-24.9 25.0-27.4 27.5-29.9 30.0-34.9 ≥ 35.0 P-value† 
HUNT-1         
No. of subjects 2821 350 650 781 571 376 93  
Female sex, No. (%) 1035 (36.7) 146 (41.7) 199 (30.6) 233 (29.8) 207 (36.3) 185 (49.2) 65 (69.9) <0.01 
Age, mean (SD), years 68.7 (9.6) 71.3 (10.3) 69.1 (9.3) 68.0 (9.5) 68.6 (9.8) 67.4 (9.2) 67.7 (8.7) <0.01 
Physical activity, No. (%)         
 Inactive 1381 (48.9) 181 (51.7) 305 (46.9) 354 (45.3) 274 (48.0) 205 (54.5) 62 (66.7)  
 Low 917 (32.5) 108 (30.9) 200 (30.8) 267 (34.2) 206 (36.1) 112 (29.8) 24 (25.8)  
 Recommended 341 (12.1) 35 (10.0) 81 (12.5) 109 (14.0) 68 (11.9) 44 (11.7) 4 (4.3) <0.01 
 High 182 (6.5) 26 (7.4) 64 (9.8) 51 (6.5) 23 (4.0) 15 (4.0) 3 (3.2)  
Diabetes status, No. (%)         
 Yes 295 (10.5) 36 (10.3) 66 (10.1) 71 (9.1) 65 (11.4) 45 (12.0) 12 (12.9)  
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 No 2526 (89.5) 314 (89.7) 584 (89.9) 710 (90.9) 506 (88.6) 331 (88.0) 81 (87.1) 0.60 
Smoking status, No. (%)         
 Never  1162 (41.2) 138 (39.4) 257 (39.6) 295 (37.8) 249 (43.6) 165 (43.9) 58 (62.4)  
 Current  636 (22.5) 119 (34.0) 164 (25.2) 171 (21.9) 102 (17.9) 68 (18.1) 12 (12.9) <0.01 
 Former  1023 (36.3) 93 (26.6) 229 (35.2) 315 (40.3) 220 (38.5) 143 (38.0) 23 (24.7)  
Alcohol consumption, No. (%)‡         
 Abstainer 597 (21.2) 87 (24.9) 131 (20.2) 156 (19.9) 120 (21.0) 78 (20.7) 25 (26.9)  
 Zero 1527 (54.1) 189 (54.0) 361 (55.5) 409 (52.4) 311 (54.5) 204 (54.3) 53 (57.0)   
 1-4 531 (18.8) 56 (16.0) 119 (18.3) 167 (21.4) 100 (17.5) 78 (20.7) 11 (11.8) 0.31 
 ≥5 166 (5.9) 18 (5.1) 39 (6.0) 49 (6.3) 40 (7.0) 16 (4.3) 4 (4.3)  
Hypertension status, No. (%)§        
 Yes 2242 (79.5) 254 (72.6) 481 (74.0) 613 (78.5) 480 (84.1) 330 (87.8) 84 (90.3)  
 No 579 (20.5) 96 (27.4) 169 (26.0) 168 (21.5) 91 (15.9) 46 (12.2) 9 (9.7) <0.01 
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Health status, No. (%)||        
 Bad 264 (9.4) 43 (12.3) 55 (8.5) 67 (8.5) 52 (9.1) 38 (10.1) 9 (9.7)  
 Not so good 1814 (64.3) 222 (63.4) 406 (62.5) 481 (62.0) 383 (67.1) 255 (67.8) 67 (72.0)  
 Good  711 (25.2) 79 (22.6) 181 (27.8) 221 (28.3) 131 (22.9) 82 (21.8) 17 (18.3) 0.06 
 Very good 32 (1.1) 6 (1.7) 8 (1.2) 12 (1.5) 5 (0.9) 1 (0.3) 0  
HUNT, Nord-Trøndelag County Health Study, Norway. 
* Calculated as weight in kilograms divided by height in meters squared. 
† For linear trend, regression analyses were used for continuous variables; χ2 tests were used for proportions of categorical variables. 
‡ Based on consumption over a 2-week period. 
§ Hypertension was defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or taking blood pressure medications. 
|| Self-reported health status. 
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Table 2. Hazard ratios of mortality according to body mass index and physical activity.   
 Deaths (n) Hazard ratio (95% CI)* Hazard ratio (95% CI)† 
All Cause    
Body mass index‡    
 
18.5-22.4    467 Reference Reference 
 22.5-24.9    814 0.86 (0.76-0.96) 0.90 (0.80-1.01) 
 25.0-27.4 1 006 0.75 (0.67-0.84) 0.80 (0.72-0.90) 
 27.5-29.9    769 0.77 (0.69-0.87) 0.80 (0.71-0.90) 
 30.0-34.9    608 0.84 (0.74-0.95) 0.83 (0.74-0.95) 
 ≥ 35.0    154 0.93 (0.77-1.12) 0.86 (0.71-1.04) 
Physical activity    
 Inactive 2 096 Reference Reference 
  Low 1 121 0.80 (0.74-0.86) 0.85 (0.79-0.92) 
    Recommended    400 0.72 (0.65-0.81) 0.81 (0.72-0.90) 
  High    201 0.73 (0.63-0.85) 0.82 (0.70-0.95) 
CVD    
Body mass index‡    
 
   18.5-22.4    280 Reference Reference 
    22.5-24.9    531 0.94 (0.81-1.09) 0.97 (0.84-1.13) 
    25.0-27.4    609 0.78 (0.68-0.90) 0.81 (0.70-0.94) 
    27.5-29.9    476 0.82 (0.71-0.95) 0.83 (0.71-0.96) 
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    30.0-34.9    385 0.92 (0.79-1.08) 0.89 (0.76-1.04) 
    ≥ 35.0      91 0.95 (0.74-1.20) 0.86 (0.67-1.09) 
Physical activity    
 Inactive 1 294 Reference Reference 
  Low    717 0.82 (0.75-0.90) 0.87 (0.79-0.96) 
    Recommended    241 0.72 (0.62-0.82) 0.80 (0.69-0.92) 
  High    120 0.70 (0.58-0.85) 0.78 (0.64-0.94) 
*Adjusted for age and examination year, and stratified by sex. 
†Ajusted for age, examination year, smoking status, diabetes mellitus, alcohol consumption,  
hypertension, health status, physical activity for body mass index and vice versa, and stratified by 
sex. 
‡ Calculated as weight in kilograms divided by height in meters squared. 
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Highlights 
• We found lower mortality risk in subjects with coronary heart disease who were 
overweight and obese.  
• In physically active subjects, however, BMI did not have a significant role for 
predicting survival.  
• These results suggest that physical activity is important to improve prognosis in 
subjects with coronary heart disease, and that body weight is of minor importance in 
secondary prevention as long as the subjects are physically active. 
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• In physically active subjects, however, BMI did not have a significant role for 
predicting survival.  
• These results suggest that physical activity is important to improve prognosis in 
subjects with coronary heart disease, and that body weight is of minor importance in 
secondary prevention as long as the subjects are physically active. 
 
 
